Anthropic wants to develop its own drugs
Anthropic has launched the Claude Science AI workbench to integrate scientific tools and data, aiming to accelerate research and healthcare interventions. The company plans to develop its own drugs for neglected diseases, but details about its drug development strategy remain unclear. AI is used throughout drug discovery, but it cannot replace human expertise, and clinical trials still require rigorous validation. The AI drug boom faces challenges in translating AI capabilities into real-world applications, with long timelines for approval and market release.
More from Theverge
I looked inside an AI generated movie, and the best parts were all human
Imagine a trio of bumbling, English lads who fantasize about becoming megastars while knocking back a few pints in a grimy pub somewhere in London. Picture the guys chortling and trying to one-up each other's idealized visions of the future with a series of increasingly glitzy fantasies in which their fame leads to access to […]
theverge.com··Mads Kristian Nylund·AI ToolsAI
Does Google even want to win at AI?
Today on Decoder, I’m talking with Hayden Field, The Verge’s senior AI reporter, about a question that’s been rocketing around the tech industry for the past week: Is Google losing the AI race? That’s because last week Google announced a bombshell reorganization of its AI division, Google DeepMind. Jeff Dean, the company’s chief scientist, is […]
theverge.com··Mads Kristian Nylund·AI ToolsAI GovernanceAI Competition
Microsoft is combining its Copilot apps ahead of a ‘super app’
Microsoft is finally beginning to combine its consumer and commercial Copilot AI assistants into a single "super app" interface, starting with the Copilot and Microsoft 365 Copilot apps. Both personal and work accounts will be moved to the new unified app, which recycles the "Microsoft Copilot" name but features an updated app icon. The single […]
theverge.com··Mads Kristian Nylund·AI ToolsAI InfrastructureAI Platforms